References
- Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American college of chest physicians evidence-based clinical practice guidelines (8th Edition). Chest. 2008;133:160S–198S.
- Horsti J. Comparison of quick and owren prothrombin time with regard to the harmonisation of the International Normalised Ratio (INR) system. Clin Chem Lab Med. 2002;40:399–403.
- Vine AK. Recent advances in haemostasis and thrombosis. Retina. 2009;29:1–7.
- Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg. 2008;106:1366–1375.
- Dunham CM, Rabel C, Hileman BM, et al. TEG® and RapidTEG® are unreliable for detecting warfarin-coagulopathy: a prospective cohort study. Thromb J. 2014;12:4.
- Franchi F, Hammad JS, Rollini F, et al. Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists. J Thromb Thrombolysis. 2015;40:118–125.
- Nascimento B, Al Mahoos M, Callum J, et al. Vitamin K-dependent coagulation factor deficiency in trauma: a comparative analysis between international normalized ratio and thromboelastography. Transfusion. 2012;52:7–13.
- Schmidt DE, Holmström M, Majeed A, et al. Detection of elevated INR by thromboelastometry and thromboelastography in warfarin treated patients and healthy controls. Thromb Res. 2015;135:1007–1011.
- Danish Society of Thrombosis and Haemostasis guidelines on perioperative regulation of anticoagulation. (Perioperativ regulering af antitrombotisk behandling (2016)) [Internet]. Available from: http://www.dsth.dk. Accessed 180421.
- Voils SA, Martin EJ, Mohammed BM, et al. Laboratory assessment of warfarin reversal with global coagulation tests versus international normalized ratio in patients with intracranial bleeding. Blood Coagul Fibrinolysis. 2015;26:443–447.
- Choi Q, Kim JE, Hyun J, et al. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays. Thromb Res. 2013;132:70–75.
- Arachchillage DR, Efthymiou M, Mackie IJ, et al. Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism. Thromb Res. 2015;135:388–393.
- Brinkman HJ. Global assays and the management of oral anticoagulation. Thromb J. 2015;13:9.
- Mussbacher M, Schrottmaier WC, Salzmann M, et al. Optimized plasma preparation is essential to monitor platelet-stored molecules in humans. PLoS One. 2017;12:e0188921.
- Tynngård N, Lindahl TL, Ramström S. Assays of different aspects of haemostasis – what do they measure? Thromb J. 2015;13:8.
- Jackson CM, Esnouf MP. Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant treatment? Clin Chem. 2005;51:483–485.
- Rumph B, Bolliger D, Narang N, et al. In vitro comparative study of hemostatic components in warfarin-treated and fibrinogen-deficient plasma. J Cardiothorac Vasc Anesth. 2010;24:408–412.
- Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur J Anaesthesiol. 2017;34:332–395.
- Lang T, von Depka M. Possibilities and limitations of thrombelastometry/thrombelastography. Hamostaseologie. 2006;26:S21–S29.
- Ogawa S, Szlam F, Chen EP, et al. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion. 2012;52:14–22.
- Theusinger OM, Schröder CM, Eismon J, et al. The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage. Anesth Analg. 2013;117:314–321.
- Ågren A, Wikman AT, Holmström M, et al. Thromboelastography (TEG®) compared to conventional coagulation tests in surgical patients–a laboratory evaluation. Scand J Clin Lab Invest. 2013;73:214–220.
- Haas T, Görlinger K, Grassetto A, et al. Thromboelastometry for guiding bleeding management of the critically ill patient: a systematic review of the literature. Minerva Anestesiol. 2014;80:1320–1335.
- Gudmundsdottir BR, Francis CW, Bjornsdottir AM, et al. Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time. Thromb Res. 2012;130:674–681.
- Spiezia L, Bertini D, Salmaso L, et al. Whole blood rotation thrombelastometry in subjects undergoing vitamin K antagonist treatment: hypo- or hypercoagulable profiles? Thromb Res. 2008;122:568–569.
- Nilsson CU, Strandberg K, Engström M, et al. Coagulation during elective neurosurgery with hydroxyethyl starch fluid therapy: an observational study with thromboelastometry, fibrinogen and factor XIII. Perioper Med (Lond). 2016;5:20.
- Silverberg E, Tornqvist F, Kander T, et al. Comparison of citrated and fresh whole blood for viscoelastic coagulation testing during elective neurosurgery. Thromb Res. 2017;156:73–79.
- Tartamella F, Vassallo MC, Berlot G, et al. Thromboelasto-graphic predictors of venous thromboembolic events in critically ill patients: are we missing something? Blood Coagul Fibrinolysis. 2016;27:804–811.
- Hincker A, Feit J, Sladen RN, et al. Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery. Crit Care. 2014;18:549.